Research and Markets: Current Position and Future Outlook for Genzyme

Dublin - Research and Markets (http://www.researchandmarkets.com/reports/c22671) has announced the addition of PharmaVitae 2005: Genzyme Global and US Analysis to their offering

This analysis examines the current position and future outlook for Genzyme in the biotechnology sector. The profile encompasses company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. An interactive forecasting and analysis tool provides continually updated quantitative and qualitative information.

Reasons to Purchase

- Benchmark Genzyme's performance against key rivals in the biotechnology sector
- Understand the impact of Genzyme's M&A strategy
- Understand the drivers of Genzymes forecast double digit growth to 2010

Topics covered include:

- Global Company Strategy
- Global Portfolio and Pipeline Analysis
- US Strategy, Portfolio and Pipeline
- Corporate Development

For more information visit http://www.researchandmarkets.com/reports/c22671

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980